World Pharma News Digest - 17.03.2014
5 views
Skip to first unread message
Ruslan David
Mar 17, 2014, 6:09:36 AM3/17/14
to worldph...@googlegroups.com
Honey is a new approach to fighting antibiotic resistance
Honey, that delectable condiment for breads and fruits, could be one sweet solution to the serious, ever-growing problem of bacterial resistance to antibiotics, researchers said. Medical professionals sometimes use honey successfully as a topical dressing, but it could play a larger role in fighting infections, the researchers predicted. Their study was part of the 247th National Meeting of the American Chemical Society (ACS), the world's largest scientific society.
Read more...
http://www.worldpharmanews.com/research/2727-honey-is-a-new-approach-to-fighting-antibiotic-resistance
Sanofi and UCB partner for breakthrough innovation in immune-mediated diseases
Sanofi (EURONEXT : SAN and NYSE : SNY) and UCB have entered into a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules, which have the potential to treat a wide range of immune-mediated diseases in areas such as gastroenterology and arthritis.
Read more...
http://www.worldpharmanews.com/sanofi/2726-sanofi-and-ucb-partner-for-breakthrough-innovation-in-immune-mediated-diseases
Building new drugs just got easier
Scientists at The Scripps Research Institute (TSRI) have developed a method for modifying organic molecules that significantly expands the possibilities for developing new pharmaceuticals and improving old ones. The innovation makes it easier to modify existing organic compounds by attaching biologically active "functional group" to drug molecules.
Read more...
http://www.worldpharmanews.com/research/2725-building-new-drugs-just-got-easier
Discrepancies between trial results reported on clinical trial registry and in journals
During a one year period, among clinical trials published in high-impact journals that reported results on a public clinical trial registry (ClinicalTrials.gov), nearly all had at least 1 discrepancy in the study group, intervention, or results reported between the 2 sources, including discrepancies in the designated primary end points for the studies, according to a study in the March 12 issue of JAMA.
Read more...
http://www.worldpharmanews.com/research/2724-discrepancies-between-trial-results-reported-on-clinical-trial-registry-and-in-journals
Scientists unlock potential heart attack drug without side effects
Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects. The Monash University research, published today in the journal, Proceedings of the National Academy of Sciences, USA (PNAS), offers new hope to thousands of people who experience heart attacks and heart failure - one of the major causes of death worldwide.
Read more...
http://www.worldpharmanews.com/research/2723-scientists-unlock-potential-heart-attack-drug-without-side-effects
PharmaNews.eu / Latest News
Cancer therapy may be too targeted
http://www.pharmanews.eu/research-and-development/1418-cancer-therapy-may-be-too-targeted
Novo Nordisk invests 550 million Danish kroner in new purification pilot plant in Denmark
http://www.pharmanews.eu/novo-nordisk/1416-novo-nordisk-invests-550-million-danish-kroner-in-new-purification-pilot-plant-in-denmark
New IMI Project to Incorporate Real Life Data into Drug Development
http://www.pharmanews.eu/research-and-development/1417-new-imi-project-to-incorporate-real-life-data-into-drug-development
Strategies on the Internet to discredit generic drugs
http://www.pharmanews.eu/research-and-development/1415-strategies-on-the-internet-to-discredit-generic-drugs
Epigenetic changes could explain type 2 diabetes
http://www.pharmanews.eu/research-and-development/1414-epigenetic-changes-could-explain-type-2-diabetes
Study suggests higher levels of omega-3 in diet are associated with better sleep
http://www.pharmanews.eu/research-and-development/1413-study-suggests-higher-levels-of-omega-3-in-diet-are-associated-with-better-sleep
Warfarin for atrial fibrillation does not worsen outcomes for patients with kidney disease
http://www.pharmanews.eu/research-and-development/1412-warfarin-for-atrial-fibrillation-does-not-worsen-outcomes-for-patients-with-kidney-disease
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Honey, that delectable condiment for breads and fruits, could be one sweet solution to the serious, ever-growing problem of bacterial resistance to antibiotics, researchers said. Medical professionals sometimes use honey successfully as a topical dressing, but it could play a larger role in fighting infections, the researchers predicted. Their study was part of the 247th National Meeting of the American Chemical Society (ACS), the world's largest scientific society.
Read more...
http://www.worldpharmanews.com/research/2727-honey-is-a-new-approach-to-fighting-antibiotic-resistance
Sanofi and UCB partner for breakthrough innovation in immune-mediated diseases
Sanofi (EURONEXT : SAN and NYSE : SNY) and UCB have entered into a scientific and strategic collaboration for the discovery and development of innovative anti-inflammatory small molecules, which have the potential to treat a wide range of immune-mediated diseases in areas such as gastroenterology and arthritis.
Read more...
http://www.worldpharmanews.com/sanofi/2726-sanofi-and-ucb-partner-for-breakthrough-innovation-in-immune-mediated-diseases
Building new drugs just got easier
Scientists at The Scripps Research Institute (TSRI) have developed a method for modifying organic molecules that significantly expands the possibilities for developing new pharmaceuticals and improving old ones. The innovation makes it easier to modify existing organic compounds by attaching biologically active "functional group" to drug molecules.
Read more...
http://www.worldpharmanews.com/research/2725-building-new-drugs-just-got-easier
Discrepancies between trial results reported on clinical trial registry and in journals
During a one year period, among clinical trials published in high-impact journals that reported results on a public clinical trial registry (ClinicalTrials.gov), nearly all had at least 1 discrepancy in the study group, intervention, or results reported between the 2 sources, including discrepancies in the designated primary end points for the studies, according to a study in the March 12 issue of JAMA.
Read more...
http://www.worldpharmanews.com/research/2724-discrepancies-between-trial-results-reported-on-clinical-trial-registry-and-in-journals
Scientists unlock potential heart attack drug without side effects
Melbourne scientists are a step closer to creating a new drug to stop a heart attack in its tracks and reduce the damage caused, without any side effects. The Monash University research, published today in the journal, Proceedings of the National Academy of Sciences, USA (PNAS), offers new hope to thousands of people who experience heart attacks and heart failure - one of the major causes of death worldwide.
Read more...
http://www.worldpharmanews.com/research/2723-scientists-unlock-potential-heart-attack-drug-without-side-effects
PharmaNews.eu / Latest News
Cancer therapy may be too targeted
http://www.pharmanews.eu/research-and-development/1418-cancer-therapy-may-be-too-targeted
Novo Nordisk invests 550 million Danish kroner in new purification pilot plant in Denmark
http://www.pharmanews.eu/novo-nordisk/1416-novo-nordisk-invests-550-million-danish-kroner-in-new-purification-pilot-plant-in-denmark
New IMI Project to Incorporate Real Life Data into Drug Development
http://www.pharmanews.eu/research-and-development/1417-new-imi-project-to-incorporate-real-life-data-into-drug-development
Strategies on the Internet to discredit generic drugs
http://www.pharmanews.eu/research-and-development/1415-strategies-on-the-internet-to-discredit-generic-drugs
Epigenetic changes could explain type 2 diabetes
http://www.pharmanews.eu/research-and-development/1414-epigenetic-changes-could-explain-type-2-diabetes
Study suggests higher levels of omega-3 in diet are associated with better sleep
http://www.pharmanews.eu/research-and-development/1413-study-suggests-higher-levels-of-omega-3-in-diet-are-associated-with-better-sleep
Warfarin for atrial fibrillation does not worsen outcomes for patients with kidney disease
http://www.pharmanews.eu/research-and-development/1412-warfarin-for-atrial-fibrillation-does-not-worsen-outcomes-for-patients-with-kidney-disease
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages